Td Asset Management Inc Bellus Health Inc. Transaction History

Td Asset Management Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	BUY	$7.14 - $8.53 $161,292 - $192,692	22,590 Added 8.65%	283,827 $2.04 Million
Q4 2022 Feb 06, 2023	SELL	$8.22 - $10.76 $56,060 - $73,383	-6,820 Reduced 2.54%	261,237 $2.15 Million
Q3 2022 Nov 07, 2022	BUY	$8.95 - $12.0 $2.4 Million - $3.22 Million	268,057 New	268,057 $2.73 Million
Q4 2020 Feb 16, 2021	SELL	$2.27 - $3.3 $75,413 - $109,632	-33,222 Closed	0 $0
Q3 2020 Nov 10, 2020	SELL	$2.14 - $12.02 $67,437 - $378,786	-31,513 Reduced 48.68%	33,222 $76,000
Q2 2020 Aug 13, 2020	BUY	$8.88 - $11.15 $293,333 - $368,317	33,033 Added 104.2%	64,735 $666,000
Q1 2020 May 15, 2020	BUY	$5.77 - $10.85 $182,920 - $343,966	31,702 New	31,702 $316,000

128K

Ticker BLU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,793,000
Description
BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. Th...

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Td Asset Management Inc with notifications on news.